Delivery Order SPE2DB20D2001-SPE2DB24FM43P
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $34,316.57 fixed-price delivery order is for the procurement of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award, valued at $11,796.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 13, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award is for the delivery of Uroxatral 10 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $8,974.85 and a completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,889.55, is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is October 27, 2023. This award does not have a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,355.89, is for the delivery of Uroxatral 10 mg tablets. It is a firm fixed-price delivery order with a completion date of September 15, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,934.88 firm-fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,254.34, is for the delivery of Uroxatral 10 mg tablets to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Uroxatral 10 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,658.40 and an ultimate completion date of December 28, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,648.17, is for the supply of 4561313272 UROXATRAL 10 MG TABLET 100S to support federal healthcare programs. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through June 2023. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of UROXATRAL 10 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $140,956.54 and is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM43PDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,025.13, is a delivery order for the supply of 4563551117 UROXATRAL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.0k | 2/5/24 |